Malapposed Struts with Cre8, Biomatrix, and Xience Stents Assessed with OCT Immediately after Implantation and at 6-Month Follow-Up: Can the Different Biomechanical Characteristics of the Three Stents Impact on Struts Malapposition?
Table 2
Baseline biohumoral data.
Cre8
Biomatrix
Xience
value
Pro-BNP (pg/mL), median (IQR)
661 (377–1551)
136 (87–804)
242 (78–660)
0.286
Troponin (µg/L), median (IQR)
0.60 (0.16–2.01)
1.08 (0.41–1.79)
2.06 (0.41–5.14)
0.577
Hemoglobin (g/dL)
12.3 ± 2.1
12.4 ± 1.1
13.2 ± 1.8
0.427
Leukocyte (109/L)
7.90 ± 2.70
6.50 ± 2.30
8.00 ± 1.70
0.233
Platelets (109/L)
193 ± 77
185 ± 54
201 ± 52
0.822
Creatinine (mg/dL)
0.99 ± 0.47
0.83 ± 0.25
0.96 ± 0.26
0.501
Total cholesterol (mg/dL)
165 ± 46
151 ± 27
188 ± 68
0.287
HDL cholesterol (mg/dL)
44 ± 16
39 ± 9
40 ± 17
0.739
LDL cholesterol (mg/dL)
97 ± 39
74 ± 36
113 ± 53
0.175
Triglycerides (mg/dL)
100 ± 54
139 ± 59
176 ± 88
0.090
HDL: high density lipoprotein, LDL: low density lipoprotein, pro-BNP: pro-brain natriuretic peptide.
